{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T22:16:52Z","timestamp":1791843412892,"version":"4.3.4"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1999,2,1]],"date-time":"1999-02-01T00:00:00Z","timestamp":917827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[1999,2,1]],"date-time":"1999-02-01T00:00:00Z","timestamp":917827200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Immunol Res"],"published-print":{"date-parts":[[1999,2]]},"DOI":"10.1007\/bf02786478","type":"journal-article","created":{"date-parts":[[2007,12,20]],"date-time":"2007-12-20T18:15:39Z","timestamp":1198174539000},"page":"89-103","source":"Crossref","is-referenced-by-count":9,"title":["Vaccine strategies to prevent rheumatic fever"],"prefix":"10.1007","volume":"19","author":[{"given":"Evelyn R.","family":"Brandt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael F.","family":"Good","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BF02786478_CR1","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/S0140-6736(96)06364-7","volume":"349","author":"GH Stollerman","year":"1997","unstructured":"Stollerman GH: Rheumatic fever. Lancet 1997;349:935\u201342.","journal-title":"Lancet"},{"key":"BF02786478_CR2","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1128\/CMR.2.3.285","volume":"2","author":"VA Fischetti","year":"1989","unstructured":"Fischetti VA: Streptococcal M protein: molecular design and biological behaviour. Clin Microbiol Rev 1989;2:285\u2013314.","journal-title":"Clin Microbiol Rev"},{"key":"BF02786478_CR3","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1084\/jem.57.4.571","volume":"57","author":"RC Lancefield","year":"1933","unstructured":"Lancefield RC: A serological differentiation of human and other groups of hemolytic streptococci. J Exp Med 1933;57: 571\u2013595.","journal-title":"J Exp Med"},{"key":"BF02786478_CR4","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/0167-5699(92)90173-5","volume":"13","author":"JH Robinson","year":"1992","unstructured":"Robinson JH, Kehoe MA: Group A streptococcal M proteins: virulence factors and protective antigens. Immunol Today 1992; 13: 362\u2013366.","journal-title":"Immunol Today"},{"key":"BF02786478_CR5","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1097\/00000441-199601000-00008","volume":"311","author":"MS Bronze","year":"1996","unstructured":"Bronze MS, Dale JB: The reemergence of serious group A streptococcal infections and acute rheumatic fever. Am J Med Sci 1996;311:41\u201354.","journal-title":"Am J Med Sci"},{"key":"BF02786478_CR6","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1093\/clinids\/11.6.928","volume":"11","author":"RW Quinn","year":"1989","unstructured":"Quinn RW: Comprehensive review of morbidity and mortality trends for rheumatic fever, streptococcal disease, and scarlet fever. The decline of rheumatic fever. Rev Infect Dis 1989;11:928\u2013953.","journal-title":"Rev Infect Dis"},{"key":"BF02786478_CR7","first-page":"146","volume":"164","author":"JR Carapetis","year":"1996","unstructured":"Carapetis JR, Wolff DR, Currie BJ: Acute rheumatic fever and rheumatic heart disease in the top end of Australia\u2019s Northern Territory. Med JAust 1996; 164:146\u2013149.","journal-title":"Med JAust"},{"key":"BF02786478_CR8","first-page":"1","volume":"4","author":"DR Martin","year":"1996","unstructured":"Martin DR, Sriprakash KS: Epidemiology of group A streptococcal disease in Australia and New Zealand. Recent Adv Microbiol 1996;4:1\u201340.","journal-title":"Recent Adv Microbiol"},{"key":"BF02786478_CR9","unstructured":"WHO Programme for prevention of rheumatic fever\/rheumatic heart disease in 16 developing countries: report for phase I (1986\u201390) Bulletin World Health Organisation. 1992;70:213\u2013218."},{"key":"BF02786478_CR10","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1128\/iai.62.5.1968-1974.1994","volume":"62","author":"DE Bessen","year":"1994","unstructured":"Bessen DE: Localisation of immunoglobulin A-binding sites within M or M-like proteins of group A streptococci. Infect Immun 1994; 62:1968\u20131974.","journal-title":"Infect Immun"},{"key":"BF02786478_CR11","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/0882-4010(92)90054-R","volume":"12","author":"HS Courtney","year":"1992","unstructured":"Courtney HS, von Hunolstein C, Dale JB, Bronze MS, Beachey EH, Hasty DL: Lipoteichoic acid and M protein: dual adhesions of group A streptococci. Microbial Pathogenesis 1992;12: 199\u2013208.","journal-title":"Microbial Pathogenesis"},{"key":"BF02786478_CR12","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1128\/iai.65.6.2472-2474.1997","volume":"65","author":"HS Courtney","year":"1997","unstructured":"Courtney HS, Liu S, Dale JB, Hasty DL: Conversion of M serotype of Streptococcus pyogenes to M serotype 5 and 18: effect on resistance to phagocytosis and adhesion to host cells. Infect Immun 1997;65:2472\u201374.","journal-title":"Infect Immun"},{"key":"BF02786478_CR13","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/j.1574-6968.1997.tb10395.x","volume":"151","author":"HS Courtney","year":"1997","unstructured":"Courtney HS, Ofek I, Hasty DL: M protein mediated adhesion of M type 24Streptococcus pyogenes stimulates release of interleukin-6 by Hep-2 tissue culture cells. FEMS Microbiol Lett 1997;151: 65\u201370.","journal-title":"FEMS Microbiol Lett"},{"key":"BF02786478_CR14","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1128\/IAI.66.3.974-979.1998","volume":"66","author":"U Fluckinger","year":"1998","unstructured":"Fluckinger U, Jones KF, Fischetti VA: Immunoglobulins to group A streptococcal surface molecule decrease adherence to and invasion of human pharyngeal cells. Infect Immun 1998;66: 974\u2013979.","journal-title":"Infect Immun"},{"key":"BF02786478_CR15","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1172\/JCI2121","volume":"101","author":"HM Schrager","year":"1998","unstructured":"Schrager HM, Alberti S, Cywes C, Dougherty GJ, Wessels MR: Hyaluronic acid capsule modulates M protein -mediated adherence and acts as a ligand for attachment of group A streptococcus to CD44 on human keratinocytes. J Clin Invest 1998;101:1708\u20131716.","journal-title":"J Clin Invest"},{"key":"BF02786478_CR16","first-page":"147","volume":"2","author":"MA Kehoe","year":"1991","unstructured":"Kehoe MA: New aspects of Streptococcus pyogenes pathogenicity. Rev Med Microbiology 1991;2: 147\u2013152.","journal-title":"Rev Med Microbiology"},{"key":"BF02786478_CR17","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.4049\/jimmunol.141.8.2760","volume":"141","author":"MW Cunningham","year":"1988","unstructured":"Cunningham MW, McCormack JM, Talaber LR, Harley JB, Ayoub EM, Muneers RS, et al.: Human monoclonal antibodies reactive with antigens of the group A streptococcus and human heart. J Immunol 1988;141:2760\u20132766.","journal-title":"J Immunol"},{"key":"BF02786478_CR18","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.4049\/jimmunol.143.8.2677","volume":"143","author":"MW Cunningham","year":"1989","unstructured":"Cunningham MW, McCormack JM, Fenderson PG, Ho M, Beachey EH, Dale JB: Human and murine antibodies cross-reactive with streptococcal M protein and myosin recognize the sequence GLN-LYS-SER-LYS-GLN in M protein. J Immunol 1989; 143:2677\u20132683.","journal-title":"J Immunol"},{"key":"BF02786478_CR19","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.4049\/jimmunol.151.5.2820","volume":"151","author":"MS Bronze","year":"1993","unstructured":"Bronze MS, Dale JB: Epitopes of streptococcal M proteins that evoke antibodies that cross-react with human brain. J Immunol 1993; 151:2820\u20132828.","journal-title":"J Immunol"},{"key":"BF02786478_CR20","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/0002-9343(83)91124-5","volume":"74","author":"V Raizada","year":"1983","unstructured":"Raizada V, Williams RCJr, Chopra P, Gopinath N, Prakash K, Sharma KB, et al.: Tissue distribution of lymphocytes in rheumatic heart valves as defined by monoclonal anti-T cell antibodies. Am J Med 1983;74:90\u201396.","journal-title":"Am J Med"},{"key":"BF02786478_CR21","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1093\/eurheartj\/14.6.758","volume":"14","author":"C Hengstenberg","year":"1993","unstructured":"Hengstenberg C, Hufnagel G., Haverich A, Olsen EG, Maisch B: De novo expression of MHC class I and class II antigens on endomyocardial biopsies from patients with inflammatory heart disease and rejection following heart transplantation. Eur Heart J 1993; 14: 758\u2013763.","journal-title":"Eur Heart J"},{"key":"BF02786478_CR22","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/eurheartj\/12.suppl_D.137","volume":"12","author":"G. Hufnagel","year":"1991","unstructured":"Hufnagel G., Maisch B: Expression of MHC class I and II antigens and the 11-2 receptor in rejection, myocarditis and dilated cardiomyopathy. Eur Heart J 1991; 12:137\u2013140.","journal-title":"Eur Heart J"},{"key":"BF02786478_CR23","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1093\/intimm\/6.8.1235","volume":"6","author":"S Pruksakorn","year":"1994","unstructured":"Pruksakorn S, Currie B, Brandt E, Phornphutkul C, Hunsakunachi S, Manmontri A, et al.: Identification of T-cell autoepitopes that crossreact with the carboxyterminal segment of the M protein of Group A streptococci. Int Immunol 1994; 6:1235\u20131244.","journal-title":"Int Immunol"},{"key":"BF02786478_CR24","doi-asserted-by":"crossref","first-page":"966","DOI":"10.4049\/jimmunol.142.3.966","volume":"142","author":"M Kotb","year":"1989","unstructured":"Kotb M, Courtney HS, Dale JB, Beachey EH: Cellular and biochemical responses of human T lymphocytes stimulated with streptococcal M proteins. J Immunol 1989; 142:966\u2013979.","journal-title":"J Immunol"},{"key":"BF02786478_CR25","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.4049\/jimmunol.149.8.2729","volume":"149","author":"S Pruksakorn","year":"1992","unstructured":"Pruksakorn S, Galbraith A, Houghten RA, Good MF: Conserved T and B cell epitopes on the M protein of group A Streptococci: Induction of bactericidal antibodies. J Immunol 1992;149: 2729\u20132735.","journal-title":"J Immunol"},{"key":"BF02786478_CR26","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1128\/iai.61.3.1062-1068.1993","volume":"61","author":"JH Robinson","year":"1993","unstructured":"Robinson JH, Case MC, Kehoe MA: Characterisation of a conserved helper-T-cell epitope from group A streptococcal M proteins. Infect Immun 1993;61: 1062\u20131068.","journal-title":"Infect Immun"},{"key":"BF02786478_CR27","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.1128\/iai.65.9.3913-3923.1997","volume":"65","author":"MW Cunningham","year":"1997","unstructured":"Cunningham MW, Antone SM, Smart M, Liu R, Kosanke S: Molecular analysis of human myosin-cross-reactive B- and T-cell epitopes of the group A streptococcal M5 protein. Infect Immun 1997;65:3913\u20133923.","journal-title":"Infect Immun"},{"key":"BF02786478_CR28","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1093\/intimm\/9.11.1723","volume":"9","author":"WA Hayman","year":"1997","unstructured":"Hayman WA, Brandt ER, Relf WA, Cooper J, Saul A, Good MF: Mapping the minimal T and B cell epitope within a peptide vaccine candidate from the conserved region of the M protein of group A streptococci. Int Immunol 1997;9: 1723\u20131733.","journal-title":"Int Immunol"},{"key":"BF02786478_CR29","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1046\/j.1365-3083.1997.d01-438.x","volume":"45","author":"H Simundsdottir","year":"1997","unstructured":"Simundsdottir H, Sigurgeirsson B, Troye-Bloomberg M, Good MF, Valdimarsson H, Jonsdottir I: Circulating T cells of patients with active psoriasis respond to streptococcal M peptides sharing sequences with human epidermal keratins. Scand J Immunol 1997; 45:688\u2013697.","journal-title":"Scand J Immunol"},{"key":"BF02786478_CR30","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1161\/01.CIR.92.3.415","volume":"92","author":"L Guilherme","year":"1995","unstructured":"Guilherme L, Cunha-Neto E, Coelho V, Snitcowsky R, Pomerantzeff PMA, Assis RV, et al.: Human heart-infiltrating T-cell clones from rheumatic heart disease patients recognize both streptococcal and cardiac proteins. Circulation 1995;92:415\u2013420.","journal-title":"Circulation"},{"key":"BF02786478_CR31","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/0896-8411(95)90011-X","volume":"8","author":"M Yoshinaga","year":"1995","unstructured":"Yoshinaga M, Figueroa F, Wahid MR, Marcus RH, Suh E, Zabriskie JB:Antigenic specificity of lymphocyte isolated from valvular specimens of rheumatic fever patients. J Autoimmun 1995;8:601\u201313.","journal-title":"J Autoimmun"},{"key":"BF02786478_CR32","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1084\/jem.158.5.1727","volume":"158","author":"JB Dale","year":"1983","unstructured":"Dale JB, Seyer JM, Beachey EH: Type specific immunogenicity of a chemically synthesised peptide fragment of type 5 streptococcal M protein. J Exp Med 1983;158: 1727\u20131732.","journal-title":"J Exp Med"},{"key":"BF02786478_CR33","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1084\/jem.162.2.583","volume":"162","author":"JB Dale","year":"1985","unstructured":"Dale JB, Beachey EH: Epitopes of streptococcal M proteins shared with cardiac myosin. J Exp Med 1985;162:583\u2013591","journal-title":"J Exp Med"},{"key":"BF02786478_CR34","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.4049\/jimmunol.151.4.2188","volume":"151","author":"JB Dale","year":"1992","unstructured":"Dale JB, Chiang EY, Lederer JW: Recombinant tetravalent group A streptococcal M protein vaccine. J Immunol 1992; 151:2188\u20132194.","journal-title":"J Immunol"},{"key":"BF02786478_CR35","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1016\/0264-410X(96)00050-3","volume":"14","author":"JB Dale","year":"1996","unstructured":"Dale JB, Simmons M, Xhiang EC, Chiang EY: Recombinant, octavalent group A streptococcal M protein vaccine. Vaccine 1996a; 14: 944\u2013948.","journal-title":"Vaccine"},{"key":"BF02786478_CR36","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.4049\/jimmunol.136.6.2287","volume":"136","author":"EH Beachey","year":"1986","unstructured":"Beachey EH, Seyer JM: Protective and non-protective epitopes of chemically synthesised peptides of the NH2-terminal region of type 6 streptococcal M Protein. J Immunol 1986;136:2287\u20132292.","journal-title":"J Immunol"},{"key":"BF02786478_CR37","first-page":"15","volume":"29","author":"S Pruksakorn","year":"1990","unstructured":"Pruksakorn S, Phornphutkul C, Boonchoo S: Prevalence of group A streptococci from school children in Chiang Mai, Thailand. Chiang Mai Med Bull 1990;29: 15\u201326.","journal-title":"Chiang Mai Med Bull"},{"key":"BF02786478_CR38","doi-asserted-by":"crossref","first-page":"3190","DOI":"10.1128\/jcm.30.12.3190-3194.1992","volume":"30","author":"WA Relf","year":"1992","unstructured":"Relf WA, Martin DR, Sriprakash KS: Identification of sequence types among the m-nontypeable group A streptococci. J Clin Microbiol 1992;30:3190\u20133194.","journal-title":"J Clin Microbiol"},{"key":"BF02786478_CR39","unstructured":"Relf WA: Molecular diversity in the M protein ofStreptococcus pyogenes. PhD thesis, University of Sydney, Sydney, Australia, 1993."},{"key":"BF02786478_CR40","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/j.1574-6968.1992.tb05188.x","volume":"91","author":"LA Single","year":"1992","unstructured":"Single LA, Martin DR:Clonal differences within M types of the group A streptococcus revealed by pulsed field gel electrophoresis. FEMS Microbiology Lett 1992; 91:85\u201390.","journal-title":"FEMS Microbiology Lett"},{"key":"BF02786478_CR41","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1097\/00006454-199404000-00004","volume":"13","author":"DR Martin","year":"1994","unstructured":"Martin DR, Voss LM, Walker SJ, Lennon D: Acute rheumatic fever in Auckland, New Zealand: spectrum of associated GAS different from expected. Pediatr. Infect Dis J 1994;13:264\u2013269.","journal-title":"Pediatr. Infect Dis J"},{"key":"BF02786478_CR42","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1084\/jem.166.3.647","volume":"166","author":"EH Beachey","year":"1987","unstructured":"Beachey EH, Seyer JM, Dale JB: Protective immunogenicity and T lymphocyte specificity of a trivalent hybrid peptides containing NH2-terminal sequences of types 5,6, and 24 M Proteins synthesised in tandem. J Exp Med 1987; 166: 647\u2013656.","journal-title":"J Exp Med"},{"key":"BF02786478_CR43","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1128\/iai.56.10.2666-2672.1988","volume":"56","author":"D Bessen","year":"1988","unstructured":"Bessen D, Fischetti VA: Influence of intranasal immunization with synthetic peptides corresponding to conserved epitopes of M protein on mucosal colonization by group A streptococci. Infect Immun 1988;56:2666\u20132672.","journal-title":"Infect Immun"},{"key":"BF02786478_CR44","doi-asserted-by":"crossref","first-page":"888","DOI":"10.4049\/jimmunol.148.3.888","volume":"148","author":"MS Bronze","year":"1992","unstructured":"Bronze MS, Courtney HS, Dale JB: Epitopes of group A streptococcal M protein that evoke crossprotective local immune responses. J Immunol1992; 148:888\u2013893.","journal-title":"J Immunol"},{"key":"BF02786478_CR45","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.4049\/jimmunol.145.4.1251","volume":"145","author":"D Bessen","year":"1990","unstructured":"Bessen D, Fischetti VA: Synthetic peptide vaccine against mucosal colonization by group A streptococci J Immunol 1990; 145:1251\u20131256.","journal-title":"J Immunol"},{"key":"BF02786478_CR46","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.4049\/jimmunol.150.10.4693","volume":"150","author":"A Vashishtha","year":"1993","unstructured":"Vashishtha A, Fischetti VA: Surface-exposed conserved region of the streptococcal M protein induces antibodies cross-reactive with denatured forms of myosin. J Immunol 1993;150:4693\u20134701.","journal-title":"J Immunol"},{"key":"BF02786478_CR47","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/S0140-6736(94)92083-4","volume":"344","author":"S Pruksakorn","year":"1994","unstructured":"Pruksakorn S, Currie B, Brandt E, Martin D, Galbraith A, Phornphutkul C, et al.: Towards a vaccine for rheumatic fever: identification of a conserved target epitope on M protein of group A streptococci. The Lancet 1994;344:639\u2013642.","journal-title":"The Lancet"},{"key":"BF02786478_CR48","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1046\/j.1365-2567.1996.d01-754.x","volume":"89","author":"ER Brandt","year":"1986","unstructured":"Brandt ER, Hayman WA, Currie B, Carapetis J, Wood Y, Jackson D, et al.: Opsonic human antibodies from an endemic population specific for a conserved epitope on the M protein of group A streptococci. Immunology 1986;89:331\u2013337.","journal-title":"Immunology"},{"key":"BF02786478_CR49","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1016\/S0264-410X(97)00178-3","volume":"16","author":"ER Brandt","year":"1997","unstructured":"Brandt ER, Hayman WA, Currie B, Pruksakorn S, Good MF: Human antibodies to the conserved region of the M protein: opsonization of heterologous strains of group A streptococci. Vaccine 1997; 16: 1805\u20131812.","journal-title":"Vaccine"},{"key":"BF02786478_CR50","first-page":"12","volume":"9","author":"W Relf","year":"1996","unstructured":"Relf W, Cooper J, Brandt E, Hayman W, Anders RF, Pruksakorn S, et al.: Mapping a conserved epitope from the M protein of group A streptococci which is the target of opsonic human antibodies. Pep Research 1996;9:12\u201320.","journal-title":"Pep Research"},{"key":"BF02786478_CR51","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1086\/520272","volume":"26","author":"DS Fedson","year":"1998","unstructured":"Fedson DS: Pneumococcal vaccination in the United states and 20 other developed countries, 1981-1996. Clin Infect Dis 1998;26: 1117\u20131123.","journal-title":"Clin Infect Dis"},{"key":"BF02786478_CR52","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1128\/IAI.66.6.2441-2446.1998","volume":"66","author":"CA Laferriere","year":"1998","unstructured":"Laferriere CA, Sood RF, de Muys JM, Michon F, Jennings HJ: Streptococcus pneumoniae type 14 polysaccharide-conjugate vaccines: length stabilisation of opsonophagocytic conformational epitopes. Infect Immun 1998;66:2441\u20132446.","journal-title":"Infect Immun"},{"key":"BF02786478_CR53","doi-asserted-by":"crossref","first-page":"3705","DOI":"10.1128\/IAI.66.8.3705-3710.1998","volume":"66","author":"TB McNeely","year":"1988","unstructured":"McNeely TB, Staub JM, Rusk CM, Blum MJ, Donnelly JJ: Antibody response to capsular polysaccharide backbone and O-acetate side groups of Streptococcus pneumoniae type 9V in humans and rhesus macaques. Infect Immun 1988;66:3705\u20133710.","journal-title":"Infect Immun"},{"key":"BF02786478_CR54","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/978-1-4615-5383-0_22","volume":"435","author":"ER Moxon","year":"1998","unstructured":"Moxon ER, Hood D, Richards J: Bacterial lipopolysaccarides: candidate vaccines to prevent Neisseria meningitis and Haemophilus influenzae infections. Adv Exp MedBiol 1998;435:237\u2013243.","journal-title":"Adv Exp MedBiol"},{"key":"BF02786478_CR55","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1093\/infdis\/171.3.593","volume":"171","author":"LG Salvadori","year":"1995","unstructured":"Salvadori LG, Blake MS, McCarty M, Tai JY, Zabriskie JB: Group A streptococcus-liposome ELISA antibody titers to group A polysaccharide and opsonophagocytic capabilities of the antibodies. J Infect Dis 1995;171:593\u2013600.","journal-title":"J Infect Dis"},{"key":"BF02786478_CR56","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/978-1-4899-1825-3_205","volume":"418","author":"JB Dale","year":"1997","unstructured":"Dale JB, Cleary PP, Fischetti VA, Kasper DL, Musser JM, Zabriskie JB: Group A and group B streptococcal vaccine development. Adv Exp Biol 1997;418:863\u2013869","journal-title":"Adv Exp Biol"},{"key":"BF02786478_CR57","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.4049\/jimmunol.161.4.2020","volume":"161","author":"EE Adderson","year":"1998","unstructured":"Adderson EE, Shikhman AR, Ward KE, Cunningham MW: Molecular analysis of polyreactive monoclonal antibodies from rheumatic carditis: human anti-N-acetylglucosamine\/ anti-myosin antibody V region genes. J Immunol 1998; 161:2020\u20132031.","journal-title":"J Immunol"},{"key":"BF02786478_CR58","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1128\/iai.64.2.503-510.1996","volume":"64","author":"Y Ji","year":"1996","unstructured":"Ji Y, McLandsbourough L, Kongagunta A, Cleary PP: C5a peptidase alters the clearance and trafficking of group A streptococcus by infected mice. Infect Immun 1996; 64:503\u2013685.","journal-title":"Infect Immun"},{"key":"BF02786478_CR59","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1128\/iai.65.6.2080-2087.1997","volume":"65","author":"Y Ji","year":"1997","unstructured":"Ji Y, Carlson B, Kondagunta A, Cleary PP: Intranasal immunization with C5a peptidase prevents nasopharyngeal colonization of mice by group A streptococcus. Infect Immun 1997;65:2080\u20132087.","journal-title":"Infect Immun"},{"key":"BF02786478_CR60","doi-asserted-by":"crossref","unstructured":"O\u2019Conner SP, Darip D, Fraley K, Nelson CM, Kaplan EL, Cleary PP: The human antibody response to Streptococcal C5a peptidase. J Infect Dis 163:109\u2013116.","DOI":"10.1093\/infdis\/163.1.109"},{"key":"BF02786478_CR61","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1016\/S0021-9258(19)39748-0","volume":"265","author":"C Chen","year":"1990","unstructured":"Chen C, Cleary P: Complete nucleotide sequence of the streptococcal C5a peptidase gene ofStreptococcus pyogenes. J Biol Chem 1990; 265:3161\u20133167.","journal-title":"J Biol Chem"},{"key":"BF02786478_CR62","doi-asserted-by":"crossref","first-page":"4536","DOI":"10.1128\/jb.172.8.4536-4542.1990","volume":"172","author":"AR Hauser","year":"1990","unstructured":"Hauser AR, Schlievert PM: Nucleotide sequence of the streptococcal pyrogenic exotoxin type B and relationship between the toxin and the streptococcal proteinase precursor. J Bacteriol 1990;172: 4536\u20134542.","journal-title":"J Bacteriol"},{"key":"BF02786478_CR63","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1128\/iai.64.3.870-877.1996","volume":"64","author":"TP Shandley","year":"1996","unstructured":"Shandley TP, Schrier D, Kapur V, Kehoe M, Musser JM, Ward PA: Streptococcal cysteine protease augments lung injury induced by products of group A streptococci. Infect Immun 1996;64:870\u2013877.","journal-title":"Infect Immun"},{"key":"BF02786478_CR64","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1006\/mpat.1994.1044","volume":"16","author":"V Kapur","year":"1994","unstructured":"Kapur V, Maffei JT, Greer RS, Li LL, Adams GJ, Musser JM: Vaccination with streptococcal cysteine protease protects mice against challenge with heterologous group A streptococci. Microb Pathogenesis 1994; 16:443\u2013450.","journal-title":"Microb Pathogenesis"},{"key":"BF02786478_CR65","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1093\/infdis\/169.2.319","volume":"169","author":"JB Dale","year":"1994","unstructured":"Dale JB. Baird RW, Courtney HS, Hasty DL, Bronze MS: Passive protection of mice against group A streptococcal pharyngeal infection by lipoteichoic acid. J Infect Dis 1994;169:319\u2013323.","journal-title":"J Infect Dis"},{"key":"BF02786478_CR66","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1128\/iai.64.5.1495-1501.1996","volume":"64","author":"JB Dale","year":"1996","unstructured":"Dale JB, Washburn RG, Marques MB, Wessels MR: Hyuaronate capsule and surface M protein in resistance to opsonization of group A streptococci. Infect Immun 1996;64:1495\u20131501","journal-title":"Infect Immun"},{"key":"BF02786478_CR67","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1128\/iai.65.1.64-71.1997","volume":"65","author":"AE Moses","year":"1997","unstructured":"Moses AE, Wessels MR, Zalcman K, Alberti S, Natanson-Yaron S, Menes T, et al.: Relative contributions of hyaluronic capsule and M protein to virulence in a mucoid strain of the group A streptococcus. Infect Immun 1997;65:64\u201371","journal-title":"Infect Immun"},{"key":"BF02786478_CR68","doi-asserted-by":"crossref","first-page":"18,452","DOI":"10.1074\/jbc.270.31.18452","volume":"270","author":"DL Crater","year":"1995","unstructured":"Crater DL, van de Rijn I: Hyaluronic acid synthesis operon (has) expression in group A streptococci. J Biol Chem 1995;270: 18,452\u201318,458.","journal-title":"J Biol Chem"},{"key":"BF02786478_CR69","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4615-1823-5","volume-title":"Vaccine Design: the Subunit and Adjuvant Approach","author":"MF Powell","year":"1995","unstructured":"Powell MF, Newman MJ: Vaccine Design: the Subunit and Adjuvant Approach. Plenum, New York, 1995."},{"key":"BF02786478_CR70","first-page":"146","volume-title":"Vaccine Design: the Subunit and Adjuvant Approach","author":"FR Vogel","year":"1995","unstructured":"Vogel FR, Powell MF: Compendium of vaccine adjuvants and excipients; in Powell MF, Newman MJ (eds): Vaccine Design: the Subunit and Adjuvant Approach. Plenum, New York, 1995, p 146."},{"key":"BF02786478_CR71","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1056\/NEJM199701093360202","volume":"336","author":"JA Stoute","year":"1997","unstructured":"Stoute JA, Slaoui M, Heppner DG, Momin P, Kester KE, Desmons P, et al.: A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. N Engl J Med 1997;336:86\u201391.","journal-title":"N Engl J Med"},{"key":"BF02786478_CR72","first-page":"37","volume":"226","author":"DL Doolan","year":"1998","unstructured":"Doolan DL, Hedstrom RC, Gardner MJ, Sedegah M, Wang H, Gramzinski RA, et al.: DNA vaccination as an approach to malaria control: current status and strategies. Curr Top Microbiol Immunol 1998;226:37\u201356.","journal-title":"Curr Top Microbiol Immunol"},{"key":"BF02786478_CR73","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1126\/science.280.5371.1875","volume":"280","author":"NL Letvin","year":"1998","unstructured":"Letvin NL: Progress in the development of an HIV-1 vaccine. Science 1998;280:1875\u20131880.","journal-title":"Science"},{"key":"BF02786478_CR74","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/nm0598supp-515","volume":"4","author":"MA Liu","year":"1998","unstructured":"Liu MA: Vaccine developments. Nat Med 1998;4(suppl):515\u2013519.","journal-title":"Nat Med"},{"key":"BF02786478_CR75","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1038\/32932","volume":"392","author":"JS Boyle","year":"1998","unstructured":"Boyle JS, Brady JL, Lew AM: Enhanced responses to a DNA vaccine encoding a fusion antigen that is directed to sites of immune induction. Nature 1998;392:408\u2013411.","journal-title":"Nature"},{"key":"BF02786478_CR76","doi-asserted-by":"crossref","unstructured":"Chappell JD, Stuart JG: Demonstration of protection in mice from lethal challenge of three M serotypes ofStreptococcus pyogenes using an M-negative vaccine. Vaccine 1993;643\u2013648.","DOI":"10.1016\/0264-410X(93)90310-T"},{"key":"BF02786478_CR77","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1084\/jem.167.6.1945","volume":"167","author":"D Bessen","year":"1988","unstructured":"Bessen D, Fischetti VA: Passive acquired mucosal immunity to group A streptococci by secretory immunoglobulin A. J Exp Med 1988;167:1945\u20131950.","journal-title":"J Exp Med"},{"key":"BF02786478_CR78","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/978-1-4684-6000-1_17","volume-title":"Immunobiology of Proteins and Peptides","author":"VA Fischetti","year":"1991","unstructured":"Fischetti VA, Bessen DE, Schneewind O, Hruby DE: Protection against streptococcal pharyngeal colonization with vaccines composed of M protein conserved regions, in Immunobiology of Proteins and Peptides. Plenum, New York, 1991, pp 159\u2013167."},{"key":"BF02786478_CR79","unstructured":"Brandt ER, Hayman WA, Currie B, Carapetis J, Jackson DC, Do KA, et al.: Functional analysis of IgA antibodies specific for a conserved epitope within the M protein of group A streptococci from Australian Aboriginal endemic communities. Submitted."},{"key":"BF02786478_CR80","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1084\/jem.168.1.25","volume":"168","author":"TP Poirier","year":"1988","unstructured":"Poirier TP, Kehoe MA, Beachey EH: Protective immunity evoked by oral administration of attenuatedaroA Salmonella typhimurium expressing cloned streptococcal M protein. J Exp Med 1988;168: 25\u201332.","journal-title":"J Exp Med"},{"key":"BF02786478_CR81","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1093\/infdis\/171.4.1038","volume":"171","author":"JB Dale","year":"1995","unstructured":"Dale JB, Chiang EC: Intranasal immunisation with recombinant group A streptococcal M protein fragment fused to the B subunit of Escherichia coli labile toxin protects mice against systemic challenge infections. J Infect Dis 1995; 171:1038\u20131041.","journal-title":"J Infect Dis"},{"key":"BF02786478_CR82","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1002\/(SICI)1521-4141(199803)28:03<1069::AID-IMMU1069>3.0.CO;2-P","volume":"28","author":"E. Medina","year":"1998","unstructured":"Medina E. Talay SR, Chatwal GS, Guzm\u00e1n CA: Fibronectin-binding protein I of Streptococcus pyogenes is a promising adjuvant for antigens delivered by mucosal route. Eur J Immunol 1998;28: 1069\u20131077.","journal-title":"Eur J Immunol"}],"container-title":["Immunologic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02786478.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/BF02786478\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02786478","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02786478.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T01:30:11Z","timestamp":1744162211000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/BF02786478"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,2]]},"references-count":82,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1999,2]]}},"alternative-id":["BF02786478"],"URL":"https:\/\/doi.org\/10.1007\/bf02786478","relation":{},"ISSN":["0257-277X","1559-0755"],"issn-type":[{"value":"0257-277X","type":"print"},{"value":"1559-0755","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,2]]}}}